Dan Sutherby

Dan has experience with both public and private health sciences, medical device and diagnostic companies. Most recently, Dan spent six years as Chief Financial Officer at IQuum, a point of care molecular diagnostics company. Previously, Dan was Chief Financial Officer at Abiomed, a publicly held medical device company serving the cardiology and heart surgery markets. Prior to Abiomed, Dan spent eight years at PerkinElmer, a global S&P 500 company, in a variety of progressive corporate and operational financial management roles including Corporate Director of Accounting and Finance, Director of Finance for the company’s Life and Analytical Sciences $1B business unit, and Corporate Vice President of Investor Relations and Corporate Communications. Earlier in his career, Dan held senior financial management positions at various publicly held manufacturing and financial services firms. Dan is a Certified Public Accountant and has both a Master of Science Degree in Finance and a Bachelor of Science Degree in Accountancy from Bentley University.